Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Ultragenyx Pharmaceutical Inc.
About RARE
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. The Company's clinical-stage pipeline consists of four product categories: biologics, small molecules, AAV gene therapy, and nucleic acid product candidates. Its products include Crysvita (burosumab), Mepsevii (vestronidase alfa), Dojolvi (triheptanoin), and Evkeeza (evinacumab). Crysvita is used for the treatment of X-linked hypophosphatemia, or XLH, in adult and pediatric patients one year of age and older. Mepsevii is used for the treatment of children and adults with mucopolysaccharidosis VII, or MPS VII, also known as Sly syndrome. Dojolvi is used for the treatment of pediatric and adult patients severely affected by long-chain fatty acid oxidation disorders, or LC-FAOD. Evkeeza is used for the treatment of homozygous familial hypercholesterolemia, or HoFH.
Find out what a historical investment in Ultragenyx Pharmaceutical Inc. would be worth today using our RARE stock calculator.
Market Capitalisation
$2.46B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.52M
High today
$25.95
Low today
$24.84
Open price
$25.71
52-week high
$42.37
52-week low
$18.29
Ready to start your investing journey with Stake?
Open an accountHow do I buy RARE shares in Australia?
Buying RARE shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Ultragenyx Pharmaceutical Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RARE
What is the ticker symbol of Ultragenyx Pharmaceutical Inc.?
The ticker symbol for Ultragenyx Pharmaceutical Inc. is RARE.
How much is one share of RARE?
One share of RARE is valued at $25.08 as of 16 May 2026.
What is the market capitalisation of Ultragenyx Pharmaceutical Inc. RARE?
As of 16 May 2026 Ultragenyx Pharmaceutical Inc. has a market cap of $2.46B.
What is the 52-week high for Ultragenyx Pharmaceutical Inc. stock?
The Ultragenyx Pharmaceutical Inc. 52-week high stock price is $42.37.
What is the 52-week low for Ultragenyx Pharmaceutical Inc. stock?
The Ultragenyx Pharmaceutical Inc. 52-week low stock price is $18.29.
Can I buy RARE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RARE shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RARE on Stake
- Buy RARE from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of RARE from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
RARE related stocks